Showing results (511-520 of 657) with videos related to

Sort By:
Pageof 66
Virology Journal|March 27, 2012
Trends in the prevalence and distribution of HTLV-1 and HTLV-2 infections in SpainAna Treviño, Antonio Aguilera, Estrella Caballero, et al.
Clinical Breast Cancer|July 25, 2008
A phase II study of weekly vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancerJuan Lucas Bayo-Calero, José I Mayordomo, Pedro Sánchez-Rovira, et al.
Nefrologia|October 23, 2018
Rationale and design of DiPPI: A randomized controlled trial to evaluate the safety and effectiveness of progressive hemodialysis in incident patientsMiguel A Suárez, Emilio García-Cabrera, Antonio Gascón, et al.
Medicina (Kaunas, Lithuania)|March 27, 2025
Presence and Evolution of Radiological Changes at 6 and 12 Months After COVID-19 Pneumonia and Their Risk FactorsCelia Roig-Martí, Antonio Navarro-Ballester, María-Pilar Fernández-García, et al.
BMC Nephrology|January 11, 2019
IHDIP: a controlled randomized trial to assess the security and effectiveness of the incremental hemodialysis in incident patientsJavier Deira, Miguel A Suárez, Francisca López, et al.
BMC Infectious Diseases|August 29, 2024
Predictors of the presence of radiological abnormalities 6 months after severe COVID-19 pneumoniaCelia Roig-Martí, Ignacio Pérez-Catalán, María Varea-Villanueva, et al.
Plos One|July 7, 2017
Physical activity domains and risk of gastric adenocarcinoma in the MCC-Spain case-control studyJosé M Huerta, María Dolores Chirlaque, Antonio J Molina, et al.
Frontiers in Public Health|October 23, 2023
One-year quality of life among post-hospitalization COVID-19 patientsIgnacio Pérez Catalán, Celia Roig Martí, Sergio Fabra Juana, et al.
Scientific Reports|November 4, 2024
Presence of COVID-19 self-reported symptoms at 12 months in patients discharged from hospital in 2020-2021: a Spanish cross-sectional studyIgnacio Pérez Catalán, Celia Roig Martí, Sofía Folgado Escudero, et al.
European Journal of Cancer (Oxford, England : 1990)|March 20, 2016
Incidence of chemotherapy-induced nausea and vomiting associated with docetaxel and cyclophosphamide in early breast cancer patients and aprepitant efficacy as salvage therapy. Results from the Spanish Breast Cancer Group/2009-02 studyAntonio Llombart-Cussac, Manuel Ramos, Elsa Dalmau, et al.
Pageof 66